1. Generics Bulletin
  2. >>Products
  3. >>Biosimilars

Teva Blends Branded And Generic Mindsets To Boost Biosimilars

US Generics COO Says Teva Is ‘Uniquely Qualified’ To Succeed In The Biosimilar Arena

 
• By Dave Wallace

Teva is “uniquely qualified” to succeed with biosimilars thanks to the dual branded and generic mindsets that it can bring to the table, Christine Baeder, senior vice president and chief operating officer of Teva’s US generics division, tells Generics Bulletin in the second part of an exclusive interview.

Brand Generic Signs
Teva is bringing both branded and generic thinking to biosimilars • Source: Alamy

Teva believes it is “uniquely qualified” to succeed with biosimilars thanks to the mixture of branded and generic thinking that it can bring to bear on the biosimilar market, according to Christine Baeder, senior vice president and chief operating officer of Teva’s US generics division.

After speaking with Generics Bulletin about the challenges and opportunities for small-molecule and complex generics in the US (Also see "Teva’s Baeder: We Need To ‘Crack The Nut’ Of Complex Generics" -

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Biosimilars

More from Products